Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
Appointed director
Director comp.
Acq. announced
Director departure
|
|
RHYTHM PHARMACEUTICALS, INC. (RYTM)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
4
| Lee Jennifer Kayden (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 11,223 shares
@ $24.1778, valued at
$271.3k
Sold 1,718 shares
@ $24.66, valued at
$42.4k
Exercised 8,591 options to buy
@ $6.8, valued at
$58.4k
Exercised 1,718 options to buy
@ $6.8, valued at
$11.7k
|
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2023 |
4
| Roberts William T. (Chief Accounting Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 912 shares
@ $17.5, valued at
$16k
Exercised 2,500 restricted stock units
@ $0 |
|
| 03/06/2023 |
4
| Mathers Edward T (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Acquired 5,771 shares
@ $0 |
|
| 02/14/2023 |
4
| Shulman Joseph (Chief Technical Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 554 shares
@ $26.87, valued at
$14.9k
Exercised 1,563 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Chien Jennifer (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 635 shares
@ $26.87, valued at
$17.1k
Exercised 2,031 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 702 shares
@ $26.87, valued at
$18.9k
Exercised 2,344 restricted stock units
@ $0 |
|
| 02/14/2023 |
4
| Mazabraud Yann (EVP, Head of International) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,031 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Cramer Pamela J. (Chief Human Resources Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 13,493 shares
@ $24.83, valued at
$335k
Exercised 13,493 options to buy
@ $19.02, valued at
$256.6k
|
|
| 07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Bedrosian Camille L (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $4.15, valued at
$83k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Shulman Joseph (Chief Technical Officer) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 557 shares
@ $6.1, valued at
$3.4k
Exercised 1,563 restricted stock units
@ $0 |
|
| 02/15/2022 |
4
| Smith Hunter C (CFO) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Sold 833 shares
@ $6.1, valued at
$5.1k
Exercised 2,344 restricted stock units
@ $0 |
|
|
|
|